SOAT1 and myeloproliferative disorder: Jak/STAT signalling is activated in haematological malignancies, particularly in myeloproliferative neoplasms and solid tumours.35, 36, 37 In PKD, Jak/STAT signalling activity is abnormally activated and promotes cystic growth.38, 39, 40, 41, 42